Results 301 to 310 of about 406,844 (342)
Some of the next articles are maybe not open access.
Brain Topography, 1992
Positron emission tomography (PET) allows for the absolute measurement of regional tissue physiological, biochemical and pharmacological processes. This ability is a consequence of the nature of positron emission and the type of tracers which can be labelled with positron emitting radionuclides. The spatial resolution of state of the art scanners is in
openaire +2 more sources
Positron emission tomography (PET) allows for the absolute measurement of regional tissue physiological, biochemical and pharmacological processes. This ability is a consequence of the nature of positron emission and the type of tracers which can be labelled with positron emitting radionuclides. The spatial resolution of state of the art scanners is in
openaire +2 more sources
Positron emission tomography in neuropsychology
Neuropsychologia, 1986By positron emission tomography (PET) of 18F-2-fluoro-2-deoxy-D-glucose (FDG) local cerebral metabolic rate for glucose (LCMRGl) can be measured in man. Normal values in cerebral cortex and basal ganglia range from 35 to 50 mumol/100 g/min, the values in gray matter structures of the posterior fossa were 25-30 mumol/100 g/min, the lowest LCMRGl was ...
W D, Heiss +4 more
openaire +2 more sources
Positron emission tomography (PET)
Journal of Medical Systems, 1982Among emerging medical diagnostic imaging modalities, positron emission tomography, often abbreviated to its acronym “PET”, belongs in the category of nuclear medicine. Indeed, the image forming variable in PET is the distribution in the structure under study of a radionuclide administered systemically in the form of a selected radiopharmaceutical ...
openaire +2 more sources
Positron Emission Tomography/Computed Tomography
Seminars in Nuclear Medicine, 2008Accurate anatomical localization of functional abnormalities obtained with the use of positron emission tomography (PET) is known to be problematic. Although tracers such as (18)F-fluorodeoxyglucose ((18)F-FDG) visualize certain normal anatomical structures, the spatial resolution is generally inadequate for accurate anatomic localization of pathology.
openaire +2 more sources
Cardiac positron emission tomography
Seminars in Nuclear Medicine, 1998Positron emission tomography (PET) is an intrinsically quantitative tool that provides a unique and unparalleled approach for clinicians and researchers to interrogate the heart noninvasively. The ability to label substances of physiological interest with positron-emitting radioisotopes has permitted insight into normal blood flow and metabolism and ...
openaire +2 more sources
POSITRON EMISSION TOMOGRAPHY INSTRUMENTATION
Radiologic Clinics of North America, 2001Positron emission tomography scanning has evolved over the past 40 years from a tool used predominantly for research to a valued clinical imaging modality. Current PET scanners must perform high-quality whole-body PET and brain PET. There are several levels of PET devices from the dedicated, high-end scanners down to the hybrid PET-SPECT systems ...
openaire +2 more sources
2014
This chapter describes the application of positron emission tomography (PET) technology to study neurotransmitter systems. The process of developing radiotracers to study the neurotransmitter systems, namely radioligands and the technical aspects of utilizing these radiotracers in PET imaging, is discussed.
Shalini Narayana +2 more
openaire +2 more sources
This chapter describes the application of positron emission tomography (PET) technology to study neurotransmitter systems. The process of developing radiotracers to study the neurotransmitter systems, namely radioligands and the technical aspects of utilizing these radiotracers in PET imaging, is discussed.
Shalini Narayana +2 more
openaire +2 more sources
Cervical Cancer: Positron Emission Tomography and Positron Emission Tomography/Computed Tomography
2009Worldwide, cervical cancer is the second most common cause of cancer-related deaths in women. Imaging has not traditionally played a large role in the diagnosis and staging of cervical cancer. Staging of cervical cancer, due to the high incidence in developing countries, is largely based on clinical examination per the Internationale de Gynecologie et ...
Lilie L. Lin, Perry W. Grigsby
openaire +1 more source
Metabolomics in cancer research and emerging applications in clinical oncology
Ca-A Cancer Journal for Clinicians, 2021Daniel R Schmidt +2 more
exaly